Literature DB >> 16903969

Postero-lateral scar tissue resulting in non-response to cardiac resynchronization therapy.

Gabe B Bleeker1, Martin J Schalij, Ernst E Van Der Wall, Jeroen J Bax.   

Abstract

In large cardiac resynchronization therapy (CRT) trials, approximately 20-30% of patients did not respond to CRT. Recent studies indicated that left ventricular (LV) dyssynchrony is needed for response to CRT. However, the presence of LV dyssynchrony may not be the only determinant of response, because some patients with LV dyssynchrony do not benefit from CRT. In the current case report, we present a patient with ischemic cardiomyopathy, NYHA class III heart failure symptoms, and substantial LV dyssynchrony on tissue Doppler imaging who underwent CRT implantation but did not respond. Following CRT, LV dyssynchrony was not reduced and the patient did not improve in clinical symptoms or LV function. The lack of LV resynchronization was explained by the presence of extensive scar tissue in the region of the tip of the LV pacing lead resulting in ineffective LV pacing. In patients with ischemic cardiomyopathy and history of previous infarction, assessment of scar tissue should be considered before CRT implantation.

Entities:  

Mesh:

Year:  2006        PMID: 16903969     DOI: 10.1111/j.1540-8167.2006.00499.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  23 in total

Review 1.  Lead positioning strategies to enhance response to cardiac resynchronization therapy.

Authors:  Dan Blendea; Jagmeet P Singh
Journal:  Heart Fail Rev       Date:  2011-05       Impact factor: 4.214

2.  Baseline myocardial perfusion predicts response to cardiac resynchronization therapy: a prospective observational study.

Authors:  Michael V Orlov; Michael Maysky; Spyridon T Akrivakis; Michael R Ujhelyi; Peter Hoffmeister; Gunjan Shukla; Susan McAllister; Gregory Kotler; Ibrahim Almasry; G Muqtada Chaudhry; Charles I Haffajee
Journal:  J Interv Card Electrophysiol       Date:  2008-08-07       Impact factor: 1.900

3.  Effect of periodic pacemaker optimization on left atrial reverse remodeling in long-term cardiac resynchronization therapy.

Authors:  Guangwei Pan; Zhiqiang Liu; Pengyi He; Yuchun Yang; Yuming Mu; Wei Han; Muhuyati Wulasihan
Journal:  J Interv Card Electrophysiol       Date:  2013-10-23       Impact factor: 1.900

4.  Bundle-branch block morphology and other predictors of outcome after cardiac resynchronization therapy in Medicare patients.

Authors:  Kenneth C Bilchick; Sandeep Kamath; John P DiMarco; George J Stukenborg
Journal:  Circulation       Date:  2010-11-01       Impact factor: 29.690

Review 5.  [Cardiac resynchronization therapy: preoperative screening. How can we reliably predict response to CRT?].

Authors:  M Kindermann; F Mahfoud; C Ukena; G Fröhlig
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2009-09

Review 6.  Clinical, laboratory, and pacing predictors of CRT response.

Authors:  Jagdesh Kandala; Robert K Altman; Mi Young Park; Jagmeet P Singh
Journal:  J Cardiovasc Transl Res       Date:  2012-02-24       Impact factor: 4.132

Review 7.  Cardiac Resynchronization Therapy in Non-Ischemic Cardiomyopathy.

Authors:  Miriam Shanks; Victoria Delgado; Jeroen J Bax
Journal:  J Atr Fibrillation       Date:  2016-02-29

8.  Lack of clinical predictors of optimal V-V delay in patients with cardiac resynchronization devices.

Authors:  Avi Fischer; Riple Hansalia; Samantha Buckley; Robin Goldberg; Martin Goldman; Paul Muntner; Davendra Mehta; W Lane Duvall
Journal:  J Interv Card Electrophysiol       Date:  2009-01-16       Impact factor: 1.900

Review 9.  Speckle tracking echocardiography: clinical applications in cardiac resynchronization therapy.

Authors:  Xiaoshan Zhang; Si Ha; Xiaolei Wang; Yilu Shi; Shasha Duan; Zhian Li
Journal:  Int J Clin Exp Med       Date:  2015-05-15

Review 10.  Potential uses of computed tomography for management of heart failure patients with dyssynchrony.

Authors:  Quynh A Truong; Udo Hoffmann; Jagmeet P Singh
Journal:  Crit Pathw Cardiol       Date:  2008-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.